ArticleEVALUATION OF THE PROPHYLACTIC AND THE POSSIBLE THERAPEUTIC EFFECTS OF SILYMARIN IN EXPERIMENTAL LIVER CIRRHOSIS
ArticleEVALUATION OF THE PROPHYLACTIC AND THE POSSIBLE THERAPEUTIC EFFECTS OF SILYMARIN IN EXPERIMENTAL LIVER CIRRHOSIS
ArticleEvaluation of silymarin and / or ginger effect on induced hepatotoxicity by carbon tetrachloride in male albino rats
ArticleEvaluation of silymarin and / or ginger effect on induced hepatotoxicity by carbon tetrachloride in male albino rats
ArticleProtective effect of silymarin and ascorbic acid in valproic acid-induced hepatic toxicity in male albino Rats
ArticleProtective effect of silymarin and ascorbic acid in valproic acid-induced hepatic toxicity in male albino Rats
ArticleModulating effect of milk thistle (Silybum marianum) oil on CD34 and vimentin expressions in fibrotic and cirrhotic liver tissues induced by CCl4 in mice
ArticleModulating effect of milk thistle (Silybum marianum) oil on CD34 and vimentin expressions in fibrotic and cirrhotic liver tissues induced by CCl4 in mice
ArticleRole of Silymarin in ameliorating the harmful effects of Diclofenac sodium on renal cortex of the adult male albino rat: Histological and immunohistochemical study
ArticleRole of Silymarin in ameliorating the harmful effects of Diclofenac sodium on renal cortex of the adult male albino rat: Histological and immunohistochemical study
ArticleA Histological Study on the Possible Adverse Effect of Sofosbuvir on Lungs of Adult Male Albino Rats
ArticleA Histological Study on the Possible Adverse Effect of Sofosbuvir on Lungs of Adult Male Albino Rats
ArticleHistological Effects of Sofosbuvir on The Kidney of Male Albino Rats and The Possible Protective Role of Vitamin C
ArticleHistological Effects of Sofosbuvir on The Kidney of Male Albino Rats and The Possible Protective Role of Vitamin C
ArticleAssessment of Fibrosis After Treatment with Direct-Acting Antiviral Drugs with or without Silymarin in Patients with Chronic Hepatitis C Related Liver Disease
ArticleAssessment of Fibrosis After Treatment with Direct-Acting Antiviral Drugs with or without Silymarin in Patients with Chronic Hepatitis C Related Liver Disease